H arnessing the differentiation potential of pluripotent stem cells could be of great clinical value for treatment of degenerative diseases. in human development, pluripotent stem cells appear transiently in the inner cell mass of the blastocyst, but if isolated and placed under appropriate culture conditions, the embryonic stem (es) cell lines can be established and propagated in vitro seemingly indefinitely. 1 Closely analogous to the es cells are embryonic carcinoma (eC) cells. eC cells are the pluripotent cells of a subset of testicular germ cell nonseminoma tumors, which arise as a consequence of neoplastic transformation of primordial germ cells. 2 numerous cell lines with different degrees of differentiation ability have been established from human teratocarcinomas. one of the best-characterized pluripotent human eC cell lines is ntera2. 3 ntera2 cells share with es cells the expression of pluripotency-associated genes (e.g., OCT4 [officially termed POU5F1] and NANOG), as well as the expression of surface antigens such as glycolipid antigens stage-specific antigen 3 (ssea3) and ssea4 and the proteoglycan antigens tra-1-60 and tra-1-81. 4,5 although ntera2 cells are propagated in vitro in an undifferentiated stem cell state, their differentiation can be induced in response to chemical agents, the best studied of which is all-trans retinoic acid. 6 following the exposure of cells to all-trans retinoic acid, cells lose their characteristic morphology and the expression of key markers of undifferentiated state (oCt4, nanog, ssea3, ssea4, tra-1-60, and tra-1-81) and begin to express a range of new markers, such as ssea1 and a2B5. 4,5,7 the rate of disappearance of markers characteristic of the undifferentiated state differs markedly, with ssea3 disappearing most rapidly. 4,5,7 therefore, ssea3 represents a particularly sensitive marker of undifferentiated stem cell state.
high-throughput technology allows rapid screening of compound effects whereby cells are subjected to a (random) collection of small compounds, followed by the identification of compounds that cause a phenotype of interest (hits). analysis of a compound's mechanism of action may link a target protein to a phenotype, thus uncovering pathways governing stem cell behavior. in addition, such compounds may directly serve as lead compounds for the development of new medications. Unlike human es cells that require complex and expensive media formulations and feeder cells or extracellular matrices for growth, eC cells are easy to culture and also less heterogeneous than es cells. these features make eC cells a convenient model for the analysis of the mechanisms underlying stem cell commitment and differentiation, particularly in high-throughput protocols.
in an effort to identify small molecules that modulate fates of eC cells-self-renewal versus differentiation and death-we designed a high-content screening assay using the ntera2 eC cells. 3 By screening a selection of 80 kinase inhibitors, we have identified inhibitors that enhanced cell survival as well as those that induced differentiation.
MAtErIALS And MEtHodS

Embryonic carcinoma and embryonic stem cell culture
ntera2 cells 3 were maintained as previously described in dulbecco's modified eagle's medium (dMeM; invitrogen, paisley, UK) supplemented with 10% fetal calf serum (fCs; hyClone, thermoscientific, Cramlington, UK) at 37 °C and 10% Co 2 in air. 3 human es cell lines used in this study were shef4, shef5, shef6, 10 and h7. 1 all es cells were maintained as colonies on mitotically inactivated mouse embryonic fibroblasts (Mefs) in medium consisting of Knockout dMeM (Ko-dMeM; invitrogen) supplemented with 20% Knockout serum replacement (invitrogen), 1 mM l-glutamine (invitrogen), 0.1 mM β-mercaptoethanol (sigma-aldrich, poole, dorset, UK), 1× nonessential amino acids (invitrogen), and 4 ng/ml basic fibroblast growth factor (fgf; invitrogen). Cells were grown at 37 °C in 5% Co 2 in air.
Compounds
the compound library used in the primary screen was the protein Kinase inhibitors library (BioMol, enzo life sciences, exeter, UK; http://www.biomol.com). the compounds are listed in Supplementary table S1. rottlerin and gf109203X used in the follow-up studies were purchased from tocris Bioscience (Bristol, UK). all-trans retinoic acid and dMso were purchased from sigma-aldrich.
Antibodies
the following primary monoclonal antibodies were prepared in house as pretitered supernatants from hybridomas: MC631 (anti-ssea3), 11 MC813-70 (anti-ssea4), 12 tra-1-60, 13 and p3X63ag8. 14 rabbit polyclonal antibody to oCt4 (ab19857-100; lot no. 138154) was purchased from abcam (Cambridge, UK). secondary antibodies used were dylight-594-conjugated goat anti-rat igM, µ-chain specific antibody (112-515-075; lot no. 82183; Jackson immunoresearch, West grove, pa), fluoresceinconjugated goat anti-mouse igg (115-095-003; lot no. 52637; Jackson immunoresearch), or dylight-488-conjugated donkey anti-rabbit igg antibody (711-485-152; lot no. 88371; Jackson immunoresearch) as appropriate to the isotype of the primary antibody.
Primary and secondary screening assays
for compound screening, ntera2 cells were plated at 2500 cells per well of a 96-well µclear flat-bottom plate (greiner Bio-one, stonehouse, UK). each compound was tested at three concentrations (0.1, 1, and 10 µM) and each concentration in triplicate wells. nine wells on each plate contained 0.1% dMso (vehicle) control, and three wells contained 10 µM all-trans retinoic acid as a differentiation control. after 5 days, the cells were washed once with dulbecco's phosphate-buffered saline (pBs) without Ca 2+ and Mg 2+ and then fixed with 4% paraformaldehyde for 15 min. this was followed by washing the cells and blocking in pBs supplemented with 10% fCs (blocking buffer) for 1 h. Cells were then incubated with ssea3 primary antibody for 1 h, washed three times in pBs, and incubated with an fitCconjugated secondary antibody for 1 h. Cells in at least three wells on the plate were incubated with secondary antibody only, to determine the background fluorescence. nuclei were counterstained with 10 µg/ml hoechst 33342 (invitrogen). images of stained cells were acquired using an automated microscopy platform (inCell analyzer 1000, ge healthcare, little Chalfont, UK). ten random fields were acquired in each well using a 10× objective. images were analyzed using developer toolbox 1.7 software (ge healthcare).
the effects of the hits from the primary screen were confirmed by retesting the compounds at a final concentration of 0.1, 1, 2.5, 5, and 10 µM, using the same protocol as in the primary screen. after 5 days, cells were fixed and stained for pluripotency markers ssea3 and oCt4. ten random fields were acquired in each well using a 10× objective. images were analyzed using developer toolbox 1.7 software.
Z′ factor assessment
the Z′ factor is a dimensionless parameter used to evaluate the performance of a screening assay. 15 to calculate the Z′ factor, cells in 30 wells of a 96-well plate were treated with 0.1% dMso as a negative control for differentiation, and cells in 30 wells were treated with 10 µM all-trans retinoic acid as a positive control for differentiation. the proportion of ssea3-positive cells was determined as described above. the Z′ factor was calculated using the following formula: 1 -[(3*sd (negative control) + 3*sd (positive control)/(mean (negative control) -mean (positive control)]. 15 
Cell growth assay
for eC and es cell growth assays, ntera2 or shef4 was plated at 2500 or 6000 cells per well, respectively, on 96-well plates in the presence of rottlerin (0.3-10 µM) or 0.1% dMso vehicle control. after 5 days, cells were washed with pBs and fixed with 4% paraformaldehyde for 15 min. after washing with pBs, nuclei were visualized by staining with 10 µg/ml hoechst 33342 (invitrogen) and imaged using the inCell analyzer 1000 (ge healthcare).
Colony-forming assays
assays were performed in six-well plates coated in Matrigel (Bd Biosciences, oxford, UK; 1:25 dilution in Ko-dMeM). h7 cells were pretreated with 0.1% dMso (control) or 5 µM rottlerin for 24 h and then harvested by treatment with trypsin. after washing once in media, the cells were resuspended in mtesr media (stemCell sciences, palo alto, Ca), and 10 000 cells were plated per well. after 7 days, cells were fixed with 4% paraformaldehyde and stained with hoechst 33342 (invitrogen). plates were imaged using the inCell analyzer 1000 (ge healthcare) and colony numbers counted from images using the developer toolbox (ge healthcare) software. Colony-forming efficiency was calculated as the ratio of the number of colonies after 7 days to the number of cells seeded.
Flow cytometry assay for cell surface markers
Cells were detached using trypsin (invitrogen) and resuspended in blocking buffer (pBs supplemented with 10% fCs). then, 5 × 10 5 cells were incubated with a primary antibody for 30 min. after washing three times with blocking buffer, cells were labeled with fitC-conjugated secondary antibody for 30 min. this was followed by washing the cells three times with blocking buffer and analyzing cell fluorescence on a Cyanadp o2 flow cytometer (Beckman Coulter, Brea, Ca). the gate for fitCpositive cells was set using control cells that were incubated with secondary antibody only or with a negative control antibody obtained from the parent myeloma cell line p3X63ag8. 14
BrdU cell cycle analysis
incorporation of 5′-bromo-2′-deoxyuridine (BrdU; sigmaaldrich) was used to identify proliferating cells. shef4 cells were treated with different concentrations of rottlerin or 0.1% dMso (vehicle control) for 24 h. Cells were then pulsed with 20 µM BrdU for 2 h, washed with pBs, and harvested by treatment with trypsin (invitrogen). after washing in pBs, cells were fixed in 70% ethanol and stored at -20 °C overnight. Cells were washed twice in pBs and then incubated with 1.5 ml of 0.2 mg/ml pepsin (sigma-aldrich) for 45 min. samples were then washed twice with 0.1 M sodium tetraborate (sigma-aldrich) and once with pBs. the cells were labeled with anti-BrdU antibody (dako, glostrup, denmark) for 45 min, washed twice with pBs, and incubated with fitC-conjugated goat anti-mouse igg+M secondary antibody (invitrogen) for 45 min at 4 °C. after washing three times in pBs with 1% fCs, the cells were treated with 20 µg/ml rnase a (sigma-aldrich) for 30 min and then resuspended in pBs containing 1% fCs and 10 µg/ml propidium iodide (pi; sigma-aldrich). Cyan adp flow cytometer with o2 optics (Beckman Coulter) was used to analyze cell fluorescence.
Annexin V apoptosis assay
shef6 cells grown in six-well plates were incubated with 0.1% dMso (control), 5 µM rottlerin, or 10 µM rottlerin in complete medium. triplicate wells were used for each condition. after an 18-h incubation, both detached and adherent cells were harvested and pooled from each well. Cells were pelleted by centrifugation, washed once with pBs and once with binding buffer (10 mM hepes, 140 mM naCl, 2.5 mM CaCl 2 , ph 7.4), and then incubated with 20 µl of annexin V-fitC (invitrogen) for 20 min at room temperature in the dark. pi (10 µg/ml; sigma-aldrich) was added to each sample followed by measurement of cell fluorescence on a Cyanadp o2 flow cytometer (Beckman Coulter).
Quantitative PCR
total rna was extracted using the rneasy Mini Kit (Qiagen, Crawley, UK) according to the manufacturer's instructions. first-strand cdna was synthesized from 1 µg rna using superscript ii reverse transcriptase (invitrogen) according to the manufacturer's instructions. Quantitative pCr was performed in a 20-µl reaction containing 1× sYBr green Jumpstart taq ready Master Mix (sigma-aldrich) and 4 pmoles of each of the forward and reverse primers. reactions were run on an iCycler iQ (Bio-rad, hercules, Ca). each sample was tested in triplicate, with the expression of GAPDH used to normalize the samples. sequences of primers for rt-pCr and qpCr were obtained from published studies or selected from target sequences using the primer3 program (http://frodo.wi.mit.edu/primer3) and are listed in Supplementary table S2 .
Real-time quantitative analysis using TaqMan Low Density Array cards
to assess the relative mrna expression levels, a taqMan human stem Cell pluripotency array (tlda) card was used (applied Biosystems, Warrington, UK). rna was transcribed to cdna using a high Capacity cdna reverse transcription Kit (applied Biosystems) according to the manufacturer's instructions. each port on the tlda card was loaded with a 100-µl reaction containing 1× taqMan Universal Master Mix (applied Biosystems) and cdna corresponding to 100 ng total rna. each sample was tested in duplicate on the same tlda card. thermal cycling was performed using the aBi 7900 (applied Biosystems). the relative quantification of gene expression was calculated using the ΔΔCt method. 16 β-ACTIN was used as the endogenous control to normalize the samples, and the vehicle control sample (0.1% dMso) was the calibrator for relative quantification. genes that amplified with a ct value of >36 (i.e., very low expression levels) were excluded from analysis.
Quantification of cellular adenosine triphosphate
total adenosine triphosphate (atp) contained in cells was quantified using the atp determination Kit (invitrogen), according to the manufacturer's instructions. Briefly, shef6 es cells were incubated with 5 µM rottlerin, 10 µM rottlerin, or 0.1% dMso for 2 h. Cells were harvested using trypsin for 3 min at 37 °C and washed once in the es medium and twice in pBs. Cell pellets were lysed in 0.1 M naoh/edta at 60 °C for 40 min. then, 200 µl of tris-edta prewarmed to 100 °C was added to the lysates and boiled for 2 min. next, 10 µl of cell lysate was placed in wells of a 96-well plate, and the reaction was initiated by adding 90 µl of the luciferase solution. the light emission was measured immediately using an optima plate reader (Biotek, potton, UK). to account for the possible differences in cell numbers between different treatments, protein concentration was measured in each sample using a BCa assay (thermoscientific) according to the manufacturer's instructions.
rESuLtS
Screening assay for stem cell survival and differentiation
to detect compounds that can bias the stem cell fate decision, we designed a high-content assay based on the detection of a marker of undifferentiated stem cell state, ssea3, following a 5-day treatment of cells with small compounds. hoechst 33342 dna intercalating dye was used to visualize the nuclei. images of cells were acquired using an automated microscopy system, the inCell analyzer 1000 (ge healthcare) ( Fig. 1a,b) . associated image analysis software allowed images to be queried for a number of features.
the first step in the image analysis protocol was delineation of nuclei in the image on the basis of hoechst 33342 fluorescence, a process termed segmentation (Fig. 1c) . a critical factor for accurate segmentation of the nuclei is the cell density as overlapping nuclei in the image may be classified as one object, causing the miscalculation of cell numbers. We found that plating of ntera2 at 2500 cells per well of a 96-well plate resulted in a sufficient density of cells for analysis after 5 days of growth but with no significant nuclei overlap (Fig. 1a,c) . the nuclear segmentation image was then used to create a "mask" (i.e., an image in which only information within the segmented area is used for analysis and the remaining portions of the image are excluded). overlaying of the mask image with the image of the ssea3 (fitC) fluorescence allowed for the fitC fluorescent signal to be detected above the nuclei only, allowing a fluorescent signal to be unambiguously associated with each cell. if the fitC signal associated with a cell was higher than the background fluorescence measured in wells where no primary antibody was added, the cell was scored as ssea3 positive (Fig. 1d) . the proportion of ssea3-positive cells was calculated by dividing the number of positive cells with the total number of cells in a well. the schema of the assay is depicted in Figure 2 .
Validation of the high-content screening assay using a known differentiation agent
We used the small-molecule all-trans retinoic acid that induces differentiation of ntera2 cells 6 to test our image-based assay. in agreement with previous measurements, 4 we observed a consistent decrease in the proportion of ssea3-positive cells from 82% ± 6% in 0.1% dMso control to 16% ± 3% in cells after a 5-day all-trans retinoic acid treatment (Fig. 3a,b) , as well as a decrease in the number of cells (Fig. 3c) . the response of individual cells to the treatment was assessed from distribution analyses of the morphological parameters such as nuclear area and form factor (a description of two-dimensional shape, calculated as the ratio of the least diameter of the object to the largest where a perfectly circular object would have the maximum value of 1) and the intensity feature hoechst 33342 fluorescence (average intensity of fluorescence over the segmented area). the distributions of these parameters changed, reflecting the phenotypic changes caused by all-trans retinoic acid treatment ( Fig. 3d-f) .
to determine the applicability of our assay for high-throughput screening, we calculated the Z′ factor for the percentage of ssea3positive cells, using all-trans retinoic acid as a differentiation control. the Z′ factor is a statistical parameter used to evaluate the performance of an assay in the ability to detect true hits (real positive results). 15 the theoretical maximum of the Z′ factor is 1. an assay that results in a Z′ higher than 0.5 is considered robust. in contrast, a Z′ factor with values below 0.5 indicates a marginal assay, whereas a value of Z′ factor below 0 indicates that it is not possible to distinguish between positive and negative results, and such an assay should not be used in screening. our assay returned a Z′ factor value of 0.7, demonstrating that the assay is reliable for use in screening.
Screen of kinase inhibitors on NTERA2 cells
pluripotent stem cells have multiple pathways present and active to maintain their identity. Conceivably, disruption of any of these pathways could de-stabilize the stem cell state. given that phosphorylation of proteins by kinases is involved in triggering a plethora of signal transduction pathways, kinase inhibitors have proved particularly useful in perturbing the stem cell fates and probing the mechanisms underlying them. 17, 18 thus, we used a collection of 80 kinase inhibitors (Supplementary table S1) to screen ntera2 cells. the kinase inhibitors tested were structurally and pharmacologically diverse and included both broad specificity compounds, such as quercetin and rottlerin, 19 as well as relatively selective inhibitors, such as sB203580 and pd98059. 19 ,20 each compound was tested at three concentrations (10, 1, and 0.1 µM) and each concentration in triplicate wells. analysis of cell numbers and the proportion of ssea3-positive cells revealed a diverse response of cells to kinase inhibitors. as an initial criterion, a 40% change in the cell number or the proportion of ssea3-positive cells was used as a hit cutoff (Fig. 4a) .
only two compounds (staurosporine and rapamycin) were completely toxic at all three concentrations tested. however, the majority of compounds tested at 10 µM caused some cell death. for example, 51% of compounds reduced the cell numbers by more than half of the control value, whereas the remaining kinase inhibitors caused a range of effects on ntera2 cell numbers ( Supplementary table S3 ). several outliers in our screen increased cell numbers above 40% of the control (Fig. 4a,b) . the compounds that induced the highest increase of cell numbers in our screen were the rho-associated kinase (roCK) inhibitor Y-27632 as well as the structurally related isoquinaline sulfonamides ha-1077, ha-1004, and h-8.
the two compounds that caused the highest downregulation of ssea3 expression in the primary screen were rottlerin and gf109203x (Fig. 4a,c) . We retested rottlerin and gf109203x in a secondary screen using a range of concentrations (0.1, 1, 2.5, 5, and 10 µM). an additional marker of pluripotency, oCt4, was used in the secondary screen. We verified a striking decrease of ssea3 observed in the initial screen and noted a similar, albeit less pronounced effect, on oCt4 ( Fig. 5a-c; Supplementary  Fig. S1 ). in the primary and secondary screens, rottlerin was more potent in decreasing ssea3 expression than gf109203Xthat is, 1 µM rottlerin caused a similar downregulation of ssea3 as 10 µM gf109203x (Figs. 4a,c and 5; Supplementary Fig. S1) . thus, we reasoned that rottlerin might be more useful in inducing differentiation than gf109203x and analyzed its effects in more detail.
Rottlerin reduces cellular viability and disrupts self-renewal of NTERA2 cells
Untreated ntera2 cells had a high nuclear/cytosol ratio and formed a densely packed monolayer. Upon rottlerin treatment, the cells increased in size, and their cytoplasms became more prominent (Fig. 6a) . the cell number decreased significantly with increasing doses of rottlerin (Fig. 6a,b) . a decrease in expression of the pluripotency-associated marker ssea3 was accompanied by the upregulation of ssea1, a marker of differentiation. 21 Unlike all-trans retinoic acid, which induced the appearance of a cell surface marker characteristic of neural differentiation, a2B5, 7 in the majority of cells, rottlerin treatment did not significantly change a2B5 expression ( Fig. 6c) . to identify the identity of differentiated cells, we compared the mrna expression of lineage-specific markers in rottlerintreated cells with that of untreated control cells (Fig. 6d) . Most notable was an increase in expression of GATA2 and CDX2. 
Rottlerin also induces differentiation of human embryonic stem cells
eC cells are regarded as malignant counterparts of es cells because of the similarities in their gene expression profiles, ability to self-renew, and the propensity to differentiate. 22 to determine whether rottlerin affects es cells in a similar manner to eC cells, we tested rottlerin on a panel of human es cell lines. treatment of cells with increasing concentrations of rottlerin for 6 days resulted in prominent morphological changes. for higher concentrations (5 and 10 µM), these changes were already notable 24 h after treatment. in contrast to the control cells, which formed densely packed colonies with well-defined borders, rottlerin-treated shef4 colonies had loosely packed larger cells (Fig. 7a) . in addition to morphological changes, the number of cells was also markedly reduced (Fig. 7a,b) . to assess the mechanism of inhibition of cell growth, we examined the cell cycle and level of apoptosis. exposure of shef4 cells to rottlerin for 24 h caused a dose-dependent accumulation of cells in g1 (Fig. 7c) , whereas flow-cytometric measurements of shef6 cells stained with annexin V revealed an increase in levels of apoptosis following a 20-h treatment with rottlerin ( Fig. 7d) . finally, as a stringent test of rottlerin's effect on stem cell selfrenewal, we examined the clonogenicity of h7 cells following a pretreatment with 5 µM rottlerin for 24 h. a more than 3-fold decrease in cloning efficiency was observed (from 0.065% ± 0.006% for control cells to 0.019% ± 0.003% for rottlerintreated ones; p = 0.000366, student t test), indicating that rottlerin inhibits the self-renewal ability of stem cells (Fig. 7e) .
expression of specific cell surface antigens was also consistent with rottlerin disrupting es cell self-renewal. Cell surface antigens characteristic for the undifferentiated state of es cells (ssea3, ssea4, tra-1-60, and tra-1-81) were all downregulated in shef4 cells in a dose-dependent manner, whereas the differentiation marker ssea1 was strongly upregulated (Fig. 8a) . Moreover, gene expression analysis of rottlerintreated shef4 cells using low-density array cards showed a uniform suppression of stem cell genes ( Fig. 8b) and upregulation of a number of lineage-specific genes, most notably CDX2 (Fig. 8c) , which was also upregulated in rottlerin-treated ntera2 cells.
rottlerin was initially reported as a protein kinase C (pKC) delta inhibitor 23 but has since been shown ineffective in inhibiting pKC delta and is considered a mitochondrial uncoupler that disrupts phosphorylation in cells by limiting atp. 24 in accordance with this mechanism, a 2-h incubation of shef6 cells with 10 µM rottlerin caused a significant decrease in atp level (Fig. 8d) .
dIScuSSIon
Compounds that can bias the fate decision of stem cells provide powerful tools for modulating stem cell behavior, investigating the underlying mechanisms, and developing new drugs. here we describe development and application of a multiparameter assay to the discovery of chemicals that alter the phenotype of ntera2 eC cells.
ntera2 cells provide a simple, well-characterized, and robust model system to study cell fate selection of both early embryonic cells as well as stem cells of germ cell tumors. 25 the undifferentiated phenotype of ntera2 cells could be lost due to the inhibition of pluripotency maintenance pathways or the activation of differentiation-associated pathways. our screening approach was designed to read out changes in the cell state regardless of the underlying mechanism by using a general marker of the undifferentiated cell state-a glycolipid antigen ssea3. 11 although the function of ssea3 remains largely unclear, extensive characterization of its expression on eC and es cells showed that it is a particularly sensitive marker of the undifferentiated state. [4] [5] [6] [7] the kinetics of ssea3 loss upon differentiation appears more rapid compared to the alternative markers (e.g., ssea4, tra-1-60, tra-1-81, or oCt4). this feature is particularly useful for high-throughput screens on cell lines, as they are carried out in small-format plates and, therefore, usually need to be completed within a few days. in our assay, a 5-day timeline was long enough to detect changes in cells undergoing differentiation, without the control cells overgrowing or changing the expression of the pluripotencyassociated markers. the assay could be further developed to include additional markers, such as ssea1 as a general marker of differentiation or indeed several lineage-specific markers (for ectoderm, endoderm, and mesoderm) to detect the fate of the differentiated cells.
the advantage of using an image-based assay over commonly employed plate reader-based assays is that it allows quantifying multiple parameters simultaneously. for example, by counting the number of nuclei and the number of cells expressing ssea3, we were able to determine the proportion of ssea3-expressing cells. this type of analysis is advantageous over measuring the fluorescent signal of ssea3 in an entire well, as it reduces the number of false-positive results that could arise as a consequence of the changes in cell numbers alone. furthermore, the effects of drugs on cell survival, proliferation, or differentiation may be manifested not only as changes in number of nuclei (reflecting numbers of cells) in a well but also as changes in nuclear size or morphology. healthy cells are characterized by round, large, and evenly stained nuclei, whereas apoptotic cells can be recognized by nuclear condensation in the early stages of apoptosis or nuclear fragmentation at a later stage. in contrast, an increase in nuclear area is indicative of cell cycle arrest and results from an increase in nuclear material. therefore, measures of nuclear size, shape (form factor), and intensity of hoechst 33342 staining were included in the assay to obtain a "phenotypic fingerprint" of each cell in the image. this type of analysis enables not only the more in-depth quantitative description of a compound's effect on cells, but measures derived from single cells provide means of detecting the heterogeneity in the population response as well as detecting rare events only measurable at the single-cell level.
We successfully applied our assay to screen for compounds that perturb stem cell fates. We chose to use a library of kinase inhibitors in the pilot screen for two main reasons. first, phosphorylation of proteins by kinases is involved in a variety of signaling pathways in cells, including cell survival, growth, and differentiation, processes involved in driving stem cell fates. second, molecular targets for most of these inhibitors are known. 19, 20 Knowledge of a compound's molecular targets facilitates the dissection of the pathways implicated. We detected a range of distinct phenotypes caused by the kinase inhibitors in the primary screen, as well as gained insight into the molecular pathways that may be responsible. for example, a striking increase in eC cell numbers was caused by a group of compounds that are potent inhibitors of both roCK and prK2. interestingly, roCK and prK2 inhibitors also promote survival of human es cells, 26, 27 indicating that common pathways are implicated in the survival of es and eC cells. roCK and prK2 are downstream effectors of rho gtpases that regulate cytoskeleton organization. activation of roCK has been implicated in coupling of actin-myosin filaments to the plasma membrane, thereby facilitating actin-myosin contractility. in contrast to some cancer cell lines where roCK activation promotes antiapoptotic effects, roCK-mediated contractility of the cytoskeleton that occurs during dissociation of human es cells results in membrane blebbing and, ultimately, cell death. 28 prevention of excessive contractile forces by roCK inhibition allows the es cells to reattach and survive. 28 these pathways have yet to be explored in eC cells and may have important implications for understanding germ cell cancer progression in vivo as well as providing information useful in developing anticancer therapies.
rottlerin was identified in our screen as a compound that induces differentiation. it also had a strong cytotoxic effect on eC and es cells. although we showed that rottlerin causes apoptosis and blocks cell proliferation, it is not clear whether differentiation was a consequence of the antiproliferative activity of rottlerin, directing a cell that cannot self-renew to an alternative fate, or whether the differentiation and cell proliferation effects were caused independently from each other. rottlerin was originally regarded as a pKCδ inhibitor, 23 but subsequent studies aimed at discerning its molecular targets showed that it is not effective at inhibiting pKCδ. in turn, rottlerin inhibits a number of other kinases, most notably ChK2, plK1, srpK1, and piM3. 19 it is of interest that the knockdown of a serine/threonine kinase pim3 in murine es cells led to increased differentiation as well as increased apoptosis. 29 similarly, plK1 depletion also resulted in increased apoptosis in various cancer cells. 30 inhibition of each of these targets individually is warranted to elucidate the extent of their contribution to the stem cell phenotype caused by rottlerin. however, it is likely that some effects of rottlerin are the result of its ability to inhibit mitochondrial respiration, which in turn causes a decrease in protein phosphorylation due to the depletion of cellular atp level. 24 We observed a drop in atp level in es cells treated with rottlerin, suggesting mitochondrial uncoupling might be at least, in part, responsible for rottlerin's effects on stem cells.
in conclusion, we have developed a high-content assay that provides quantitative information for analyzing effects of small compounds on the stem cell phenotype. We have applied this assay in a screen of small compounds and showed that the assay can identify hits causing distinct cellular phenotypes. our study demonstrates the power of combining small-molecule screening with high-content technology, and this approach should also provide a useful platform for rnai screens aimed at discerning signaling pathways underlying stem cell biology.
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